Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: Novartis 2Q | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Financial Report: Novartis 2Q

Recently launched products generated sales of $2.4 billion, 21% of total sales, including A(H1N1) pandemic vaccines.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Novartis 2Q

2Q Revenues: $11.7 billion (+11%)

2Q Earnings: $2.4 billion (+19%)

YTD Revenues: $23.8 billion (+18%)

YTD Earnings: $5.4 billion (+29%)

Comments: Recently launched products generated sales of $2.4 billion, 21% of total sales, including A(H1N1) pandemic vaccines. Pharmaceuticals revenue was $7.7 billion, up 8%. Vaccines and Diagnostics sales were $0.6 billion, up 135%, which included $0.2 billion of A(H1N1) pandemic vaccine sales. Sandoz sales were $2.0 billion, up 13%, attributed to new product launches and the contribution of EBEWE Pharma.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters